OBJECTIVES: Genome-wide association studies (GWAS) have led to the identification of single nucleotide polymorphisms in or near several loci that are associated with the risk of obesity and nonalcoholic fatty liver disease (NAFLD). We hypothesized that missense variants in GWAS and related candidate genes may underlie cases of extreme obesity and NAFLD-related cirrhosis, an extreme manifestation of NAFLD. METHODS: We performed whole-exome sequencing on 6 Caucasian patients with extreme obesity [mean body mass index (BMI) 84.4] and 4 obese Caucasian patients (mean BMI 57.0) with NAFLD-related cirrhosis. RESULTS: Sequence analysis was performed on 24 replicated GWAS and selected candidate obesity genes and 5 loci associated with NAFLD. No missense variants were identified in 19 of the 29 genes analyzed, although all patients carried at least 2 missense variants in the remaining genes without excess homozygosity. One patient with extreme obesity carried 2 novel damaging mutations in BBS1 and was homozygous for benign and damaging MC3R variants. In addition, 1 patient with NAFLD-related cirrhosis was compound heterozygous for rare damaging mutations in PNPLA3. CONCLUSIONS: These results indicate that analyzing candidate loci previously identified by GWAS analyses using whole-exome sequencing is an effective strategy to identify potentially causative missense variants underlying extreme obesity and NAFLD-related cirrhosis.
OBJECTIVES: Genome-wide association studies (GWAS) have led to the identification of single nucleotide polymorphisms in or near several loci that are associated with the risk of obesity and nonalcoholic fatty liver disease (NAFLD). We hypothesized that missense variants in GWAS and related candidate genes may underlie cases of extreme obesity and NAFLD-related cirrhosis, an extreme manifestation of NAFLD. METHODS: We performed whole-exome sequencing on 6 Caucasian patients with extreme obesity [mean body mass index (BMI) 84.4] and 4 obese Caucasian patients (mean BMI 57.0) with NAFLD-related cirrhosis. RESULTS: Sequence analysis was performed on 24 replicated GWAS and selected candidate obesity genes and 5 loci associated with NAFLD. No missense variants were identified in 19 of the 29 genes analyzed, although all patients carried at least 2 missense variants in the remaining genes without excess homozygosity. One patient with extreme obesity carried 2 novel damaging mutations in BBS1 and was homozygous for benign and damaging MC3R variants. In addition, 1 patient with NAFLD-related cirrhosis was compound heterozygous for rare damaging mutations in PNPLA3. CONCLUSIONS: These results indicate that analyzing candidate loci previously identified by GWAS analyses using whole-exome sequencing is an effective strategy to identify potentially causative missense variants underlying extreme obesity and NAFLD-related cirrhosis.
Authors: Uyenlinh L Mirshahi; Christopher D Still; Kathryn K Masker; Glenn S Gerhard; David J Carey; Tooraj Mirshahi Journal: J Clin Endocrinol Metab Date: 2011-10-05 Impact factor: 5.958
Authors: Kyle F Cox; Natalie C Kerr; Marina Kedrov; Darryl Nishimura; Barbara J Jennings; Edwin M Stone; Val C Sheffield; Alessandro Iannaccone Journal: Vision Res Date: 2012-08-24 Impact factor: 1.886
Authors: Elizabeth K Speliotes; Laura M Yerges-Armstrong; Jun Wu; Ruben Hernaez; Lauren J Kim; Cameron D Palmer; Vilmundur Gudnason; Gudny Eiriksdottir; Melissa E Garcia; Lenore J Launer; Michael A Nalls; Jeanne M Clark; Braxton D Mitchell; Alan R Shuldiner; Johannah L Butler; Marta Tomas; Udo Hoffmann; Shih-Jen Hwang; Joseph M Massaro; Christopher J O'Donnell; Dushyant V Sahani; Veikko Salomaa; Eric E Schadt; Stephen M Schwartz; David S Siscovick; Benjamin F Voight; J Jeffrey Carr; Mary F Feitosa; Tamara B Harris; Caroline S Fox; Albert V Smith; W H Linda Kao; Joel N Hirschhorn; Ingrid B Borecki Journal: PLoS Genet Date: 2011-03-10 Impact factor: 5.917
Authors: Olivier Harismendy; Vikas Bansal; Gaurav Bhatia; Masakazu Nakano; Michael Scott; Xiaoyun Wang; Colette Dib; Edouard Turlotte; Jack C Sipe; Sarah S Murray; Jean Francois Deleuze; Vineet Bafna; Eric J Topol; Kelly A Frazer Journal: Genome Biol Date: 2010-11-30 Impact factor: 13.583
Authors: Michael J Clark; Rui Chen; Hugo Y K Lam; Konrad J Karczewski; Rong Chen; Ghia Euskirchen; Atul J Butte; Michael Snyder Journal: Nat Biotechnol Date: 2011-09-25 Impact factor: 68.164
Authors: Goncalo R Abecasis; Adam Auton; Lisa D Brooks; Mark A DePristo; Richard M Durbin; Robert E Handsaker; Hyun Min Kang; Gabor T Marth; Gil A McVean Journal: Nature Date: 2012-11-01 Impact factor: 49.962
Authors: E Rodríguez-Gallego; M Guirro; M Riera-Borrull; A Hernández-Aguilera; R Mariné-Casadó; S Fernández-Arroyo; R Beltrán-Debón; F Sabench; M Hernández; D del Castillo; J A Menendez; J Camps; R Ras; L Arola; J Joven Journal: Int J Obes (Lond) Date: 2014-03-28 Impact factor: 5.095
Authors: Ankita Parihar; G Craig Wood; Xin Chu; Qunjan Jin; George Argyropoulos; Christopher D Still; Alan R Shuldiner; Braxton D Mitchell; Glenn S Gerhard Journal: Front Genet Date: 2014-08-05 Impact factor: 4.599
Authors: Carlos J Pirola; Diego Flichman; Hernán Dopazo; Tomas Fernández Gianotti; Julio San Martino; Cristian Rohr; Martin Garaycoechea; Carla Gazzi; Gustavo O Castaño; Silvia Sookoian Journal: Hepatol Commun Date: 2018-09-05